Tag Archive: Purdue Pharma


 

 

oxy lawsuit.jpg

 

Massachusetts has filed a lawsuit against 16 top executives of Purdue Pharma, the maker of the popular drug OxyContin, claiming they misled doctors, patients and the public about the dangers posed by the opioid-based painkiller.  Attorney General Maura Healey said “Their strategy was simple: The more drugs they sold, the more money they made—and the more people died. We found that Purdue engaged in a multibillion-dollar enterprise to mislead us about their drugs. Purdue pushed prescribers to give higher doses to keep patients on drugs for longer periods of time, without regard to the very real increased risk of addiction, overdose and death.”  Texas, Florida, Nevada, North Carolina, North Dakota and Tennessee have filed similar lawsuits in state courts against the drug maker, whose headquarters are in Stamford, Connecticut.

The Texas’ lawsuit accuses Purdue Pharma, the privately held manufacterer of OxyContin, of violating the Texas Deceptive Trade Practices Act by aggressively selling its products “when it knew their drugs were potentially dangerous and that its use had a high likelihood of leading to addiction,” state Attorney General Ken Paxton said.  “As Purdue got rich from sales of its opioids, Texans and others across the nation were swept up in a public health crisis that led to tens of thousands of deaths each year due to opioid overdoses,” Paxton said.

State officials in Arizona, Alabama, Delaware, Illinois, Kentucky, Louisiana, Mississippi, Missouri, Montana, New Hampshire, New Jersey, New Mexico, Ohio, Oklahoma, South Carolina and West Virginia,  — sued various pain-killer manufacturers and distributors for their roles in helping the opioid epidemic grow.  In 2007, Purdue Pharma did not admit wrongdoing when it paid $19.5 million to settle lawsuits with 26 states and the District of Columbia after being accused of aggressively marketing OxyContin to doctors while downplaying the risk of addiction.  Nevada, North Carolina, Tennessee and Texas were part of that agreement while Florida and North Dakota were not.

Opioids were the cause of nearly 42,250 deaths in 2016, according to the federal Centers for Disease Control and Prevention.   Research suggests that since heroin and opioid painkillers, (including prescription ones) act similarly in the brain.  Opioid painkillers are often referred to by some doctors as “heroin lite” and taking one (even “as directed”) can increase one’s susceptibility to becoming hooked on the other.  Drug overdoses are now the leading cause of death for Americans under the age of 50, with opioids as the number-one driver.

Deaths from opioids (including fentynals) have been rising sharply for years with an estimated 100 drug overdoses a day across the country.  Experts say the epidemic could kill nearly half a million people across America over the next decade as the crisis of addiction and overdose accelerates.

 

 

 

Advertisements

 

 

 

opioid epidemic.jpgNew York City Mayor Bill de Blasio has announced the city is suing major pharmaceutical manufacturers and distributors over their role in the opioid crisis.   The lawsuit filed in state Supreme Court seeks $500 million in damages for current and future costs from what the mayor described as “corporate drug pushers.”  Among the companies being sued are Purdue Pharma, which is the maker of OxyContin, Teva Pharmaceuticals USA Inc., Johnson & Johnson, and Janssen Pharmaceuticals.

The lawsuit alleges opioid manufacturers used deceptive marketing to flood the city with prescription painkillers, creating “a substantial burden on the city through increased substance use treatment services, ambulatory services, emergency department services, inpatient hospital services, medical examiner costs, criminal justice costs and law enforcement costs.”

John Puskar, director of public affairs at Purdue, issued a statement saying the company “vigorously” denies the charges leveled by the city.  “We are deeply troubled by the prescription and illicit opioid abuse crisis, and are dedicated to being part of the solution. As a company grounded in science, we must balance patient access to FDA-approved medicines, while working collaboratively to solve this public health challenge. Although our products account for approximately 2% of the total opioid prescriptions, as a company, we’ve distributed the CDC Guideline for Prescribing Opioids for Chronic Pain, developed three of the first four FDA-approved opioid medications with abuse-deterrent properties and partner with law enforcement to ensure access to naloxone. We vigorously deny these allegations and look forward to the opportunity to present our defense.”

The opioid crisis killed nearly 64,000 Americans in 2016 and provisional data for 2017 from the CDC show no signs of the epidemic abating, with an estimate of more than 66,000 overdose deaths for the year.   While overdose rates increased in all age groups, rises were most significant in those between the ages of 25 and 54.  Overdoses are now the leading cause of death of Americans under the age of 50.  “Based on what we’re seeing, it doesn’t look like it’s getting any better,” said Bob Anderson, chief of the mortality statistics branch at the National Center for Health Statistics.